Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01701895 · ClinicalTrials.gov registry record

Assessing Short and Long Term Compliance With Caloric Intake in HIV Positive Women Taking Complera

A clinical trial of HIV-1-infection, sponsored by Prema Menezes, PhD, PA-C.

Completed
Registry status
33
Enrollment target
1
Study location

NCT01701895 is a study of HIV-1-infection that has completed, run by Prema Menezes, PhD, PA-C. The registered enrollment target is 33 participants, below the 351-participant average among 71 other HIV-1-infection trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01701895, a study of HIV-1-infection, has completed, sponsored by Prema Menezes, PhD, PA-C.

COMPLETED
Registry status
33 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research study is to evaluate how easy it is for female HIV- positive subjects taking Complera to comply with the dietary requirement using a food diary in the short term (4 weeks) and long term (24 weeks and 48 weeks) and to determine association between calorie intake and virologic suppression. A secondary goal of the study is to evaluate subjects' attitudes towards contraception.

Conditions Studied

Study Locations (1)

North Carolina

  • University of North Carolina at Chapel Hill - Chapel Hill

Trial Details

FieldValue
Enrollment Target 33 participants
Start Date 2012-10
Est. Completion 2015-10

Sponsor

Prema Menezes, PhD, PA-C

1 total trials

What the Registry Record Tells You About NCT01701895

The ClinicalTrials.gov registry entry for NCT01701895 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 351-participant average among 71 other HIV-1-infection trials with a reported enrollment target (91% lower). The listed sponsor is Prema Menezes, PhD, PA-C, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV-1-infection appearing as the primary indexed condition, and to 0 interventions.

NCT01701895 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT01701895 about?

NCT01701895 is a clinical study titled "Assessing Short and Long Term Compliance With Caloric Intake in HIV Positive Women Taking Complera". The purpose of this research study is to evaluate how easy it is for female HIV- positive subjects taking Complera to comply with the dietary requirement using a food diary in the short term (4 weeks) and long term (24 weeks and 48 weeks) and to determine association between calorie intake and virol...

What is the current status of trial NCT01701895?

This trial is currently completed. The enrollment target is 33 participants. The study started on 2012-10. Estimated completion is 2015-10.

What conditions does trial NCT01701895 study?

This clinical trial studies the following conditions: HIV-1-infection.

Who is sponsoring clinical trial NCT01701895?

This trial is sponsored by Prema Menezes, PhD, PA-C, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01701895 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV-1-infection

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.